Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms (a report from the Multicenter Chest Pain Study),☆☆

https://doi.org/10.1016/0002-9149(89)90857-6Get rights and content
Under a Creative Commons license
open archive

Abstract

To determine the prevalence and characteristics of acute myocardial infarction (AMI) patients who present to emergency departments with normal or nonspecific electrocardiograms (ECGs), data were analyzed from 7,115 consecutive patients in the Multicenter Chest Pain Study. AMI patients with normal or nonspecific initial ECGs (n = 107) were less likely to have a past history of coronary artery disease or to be diaphoretic on presentation (p < 0.01) than AMI patients with initial ECGs highly suggestive of AMI (n = 811). The overall probability of AMI among patients with chest pain and initially normal or nonspecific ECGs was 3%, but ranged from <1 to 17% depending on the patient's age and sex and whether the patient had pressuretype pain or pain radiating to the shoulder, neck or arms. Among initially admitted patients, the time elapsed between onset of pain and presentation was similar in both groups. However, the time between onset of pain and definitive diagnosis of AMI by enzymes or clinical course was longer in patients with initially normal or nonspecific electrocardiograms (8.3 vs 7.5 hours, p < 0.05), their peak creatine kinase levels were lower (mean 643 vs 1,032 mg/dl, p < 0.001) and their mortality was slightly tower (6 vs 12%, p = 0.10). These findings suggest that AMI patients with initially normal or nonspecific ECGs may have a less severe shortterm clinical outcome.

Cited by (0)

See Appendix.

☆☆

This study was supported in part by grants from the John A. Hartford Foundation, New York, New York (83102-2H), and from the Robert Wood Johnson Foundation, Princeton, New Jersey (12543).

1

Dr. Rouan was a Teaching and Research Scholar of the American College of Physicians and was supported in part by a grant to the Training Program in Clinical Effectiveness from the W.K. Kellogg Foundation.

2

Dr. Lee is the recipient of a Public Health Service Clinical Investigator Award (HL01594-01) from the National Heart, Lung, and Blood Institute, Bethesda, Maryland.